About 75 drug candidates based on synlet gene pairs are being evaluated for the treatment of various types of cancers

Advances in screening technologies have enabled the identification of interactive gene combinations, enabling the development of lead candidates that leverage the principle of synthetic lethality for cancer treatment
 
To order this 485+ page report, which features 195+ figures and 200+ tables, please visit this link
 
The USD 8 billion (by 2030) financial opportunity within the synthetic lethality-based drugs and targets market has been analyzed across the following segments:
Type of molecule
Small Molecule
Biologic
Target disease indication
  • Breast Cancer
  • Colorectal Cancer
  • Fallopian Tube Cancer
  • Gastric Cancer
  • Head and Neck Cancer
  • Lung Cancer
  • Ovarian Cancer
  • Peritoneal Cancer
  • Others
  • Type of synlet target
  • APE1 / Ref-1
  • Chk1
  • GLS1
  • PARP
  • Pol θ
  • PP2A
  • Wee1
Route of administration 
Oral
Intravenous
Key geographical regions
North America
Europe
Asia Pacific
  • Rest of the World


The https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html, report features the following companies, which we identified to be key players in this domain: 
  • AbbVie
  • AstraZeneca
  • AtlasMedx
  • BeiGene
  • Chordia Therapeutics
  • Clovis Oncology
  • GlaxoSmithKline
  • IDEAYA Biosciences
  • Mission Therapeutics
  • Pfizer
  • Repare Therapeutics
  • Sierra Oncology

SyntheX Labs

 
Table of Contents
 
1. Preface

2. Executive Summary

3. Introduction to DNA Damage and Repair Systems


4. Introduction to Synthetic Lethality


5. Market Overview


6. Company Profiles


7. Emerging Trends on Social Media


8. Publication Analysis


9. Abstract Analysis 


10. Academic Grants Analysis


11. Funding and Investment Analysis


12. Target Benchmark Analysis
 
13. Role of Companion Diagnostics in Synthetic Lethality
 
14. Market Forecast


15. Concluding Remarks


16. Executive Insights
17. Appendix 1: Tabulated Data
18. Appendix 2: List of Companies and Organizations
 
 
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html
 
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
 [email protected]

You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
BenJ
0 Karma
628 Posts

Made with by Mamby